Mohammad Azab

Mohammad Magdy Mohamed Azab currently works at Pyramisa Hotels, as Vice Chairman & MD-Financial Affairs, Lisata Therapeutics, Inc., as Independent Director from 2022, American Society of Clinical Oncology, Inc., as Member, American Society of Hematology, as Member, European Society for Medical Oncology, as Member, and International Association for the Study of Lung Cancer, as Member.
Dr. Azab also formerly worked at Intradigm Corp., as President, Chief Executive Officer & Director from 2006 to 2010, Astex Pharmaceuticals, Inc., as Chairman from 2020 to 2022, Sernova Biotherapeutics, Inc., as Independent Director from 2021 to 2023, Chemokine Therapeutics Corp., as Director from 2006 to 2007, Xenon Pharmaceuticals, Inc., as Independent Director from 2003 to 2024, DURECT Corp., as Independent Director from 2021 to 2025, QLT, Inc., as Chief Medical Officer, EVP-Research & Development from 1997 to 2005, SuperGen, Inc., as Chief Medical Officer from 2009 to 2011, Astex Therapeutics Ltd., as Chief Medical Officer, American Association for Cancer Research, as Member, and Sanofi-Synthelabo, Inc., as Manager-International Medical Oncology from 1989 to 1992.
Dr. Azab received his doctorate degree in 1979 from the University of Cairo, graduate degree from Université de Paris XI Paris Sud, graduate degree from Université Pierre et Marie Curie, and Masters Business Admin degree in 2001 from Richard Ivey School of Business.